Skip to main content

Table 1 Baseline characteristics of people who use drugs enrolled in the VIDUS and ACCESS cohorts, stratified by use of withdrawal management services in the previous 6 months, Vancouver, Canada, Dec 2005 to May 2016

From: Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada

Characteristic

Total (%)

(n = 2001)

Use of Withdrawal Management Services

p – value**

Yes (%)

(n = 69)

No (%)

(n = 1932)

Male

1313 (65.6)

49 (71.0)

1264 (65.4)

0.262

White ethnicity

1179 (58.9)

45 (65.2)

1134 (58.7)

0.279

Age (median, Q1-Q3)

41.5 (34.6–47.6)

39.8 (32.0–45.6)

41.6 (34.9–47.7)

0.037

Homelessness*

718 (35.9)

35 (50.7)

638 (35.4)

0.009

In a stable relationship

578 (28.9)

19 (27.5)

559 (28.9)

0.754

Incarceration*

331 (16.5)

12 (17.4)

319 (16.5)

0.854

Regular Employment*

474 (23.7)

22 (31.9)

452 (23.4)

0.103

Sex Work*

315 (15.7)

12 (17.4)

303 (15.7)

0.713

Daily Heroin Use*

540 (27.0)

25 (36.2)

515 (26.7)

0.080

Daily Cocaine Use*

184 (9.2)

11 (15.9)

173 (9.0)

0.049

Daily Methamphetamine Use*

121 (6.0)

9 (13.0)

112 (5.8)

0.013

Daily Prescription Opioid Use*

125 (6.2)

5 (7.2)

120 (6.2)

0.728

High Risk Alcohol Use*†

251 (12.5)

6 (8.7)

245 (12.7)

0.325

Binge Use (any substance)*

801 (40.0)

34 (49.3)

767 (39.7)

0.118

Injection Drug Use (any substance)*

1795 (89.7)

64 (92.8)

1731 (89.6)

0.402

Overdose*

152 (7.6)

11 (15.9)

141 (7.3)

0.008

Use at Supervised Injection Facility*

991 (49.5)

41 (59.4)

950 (49.2)

0.103

Hospital Admission*

422 (21.1)

18 (26.1)

404 (20.9)

0.300

Mental Health diagnosis

988 (49.4)

44 (63.8)

944 (48.9)

0.015

Opioid Agonist Therapy*

837 (41.8)

20 (29.0)

817 (42.3)

0.027

Other Addiction Treatment/Supports*‡

298 (14.9)

37 (53.6)

261 (13.5)

< 0.001

  1. * in the last 6 months
  2. † as per NIAAA guidelines (> 3 drinks/day or 7 drinks/week for females and > 4 drinks/day or 14 drinks/week for males)
  3. ‡ other than withdrawal management services or opioid agonist therapy
  4. ** Pearson’s Chi Square test and Mann-Whitney test were used to examine the baseline sample characteristics